Literature DB >> 1750756

Cerebral blood flow velocity changes after rapid administration of surfactant.

F Cowan1, A Whitelaw, D Wertheim, M Silverman.   

Abstract

A computer linked Doppler system was used to make continuous measurements of cerebral blood flow velocity (CBFV) from the middle cerebral artery, mean arterial blood pressure (MAP) from the umbilical artery, and heart rate before, during, and for 20 minutes after the endotracheal administration of 200 mg/kg of porcine surfactant in 10 preterm infants with respiratory distress syndrome. Within two minutes of surfactant administration, there was a median fall of 6 mm Hg (15%) fall in MAP and 36% in CBFV. There was a change in the Doppler spectra with almost complete loss of diastolic velocities. A rapid reduction in pulmonary vascular resistance with consequent left to right ductal shunting is one possible cause. These acute changes in MAP and CBFV after bolus surfactant administration may increase the risk of intraventricular haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750756      PMCID: PMC1590278          DOI: 10.1136/adc.66.10_spec_no.1105

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Acute effects of instillation of surfactant in severe respiratory distress syndrome.

Authors:  H L Halliday; F B McCord; B G McClure; M M Reid
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

2.  Acute and protracted effects of intratracheal surfactant application on internal carotid blood flow velocity, blood pressure and carbondioxide tension in very low birth weight infants.

Authors:  G Jorch; H Rabe; M Garbe; E Michel; L Gortner
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

3.  Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome.

Authors:  F B McCord; T Curstedt; H L Halliday; G McClure; M M Reid; B Robertson
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

4.  Transient hyperoxia and cerebral blood flow velocity in infants born prematurely and at full term.

Authors:  S Niijima; D B Shortland; M I Levene; D H Evans
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

5.  Range-gated pulsed Doppler ultrasonographic evaluation of carotid arterial blood flow in small preterm infants with patent ductus arteriosus.

Authors:  W D Wilcox; T A Carrigan; K J Dooley; D P Giddens; F D Dykes; A Lazzara; J L Ray; P A Ahmann
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

6.  Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial.

Authors:  G Enhorning; A Shennan; F Possmayer; M Dunn; C P Chen; J Milligan
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

7.  Dicarboxylicaciduria and secondary carnitine deficiency in glycogenosis type IV.

Authors:  P D Maaswinkel-Mooy; B J Poorthuis; H H van Gelderen; J J van de Kamp
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

8.  Carbon dioxide reactivity of the cerebral circulation in extremely premature infants: effects of postnatal age and indomethacin.

Authors:  M I Levene; D Shortland; N Gibson; D H Evans
Journal:  Pediatr Res       Date:  1988-08       Impact factor: 3.756

9.  Cerebral blood flow, PaCO2 changes, and visual evoked potentials in mechanically ventilated, preterm infants.

Authors:  G Greisen; W Trojaborg
Journal:  Acta Paediatr Scand       Date:  1987-05

10.  Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.

Authors:  G P Heldt; E Pesonen; T A Merritt; W Elias; D J Sahn
Journal:  Pediatr Res       Date:  1989-03       Impact factor: 3.756

View more
  14 in total

Review 1.  Current perspectives on the drug treatment of neonatal respiratory distress syndrome.

Authors:  D G Sweet; H L Halliday
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 2.  The light still shines, but not that brightly? The current status of perinatal near infrared spectroscopy.

Authors:  S E Nicklin; I A-A Hassan; Y A Wickramasinghe; S A Spencer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

3.  Cerebral blood flow velocity changes after rapid administration of surfactant.

Authors:  H Halliday; B Robertson
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

4.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 5.  Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.

Authors:  L R Wiseman; H M Bryson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

6.  Nebulisation of surfactants in an animal model of neonatal respiratory distress.

Authors:  T F Fok; M al-Essa; M Dolovich; F Rasid; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

7.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

8.  Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.

Authors:  E Saliba; M Nashashibi; M C Vaillant; C Nasr; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

9.  Surfactant therapy in respiratory distress syndrome: the effect of a learning curve in improving outcome.

Authors:  S M Gormally; T A Clarke; A Krishnan; M Ali; T G Matthews
Journal:  Ir J Med Sci       Date:  1993-11       Impact factor: 1.568

10.  Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors.

Authors:  E Herting; O Gefeller; C P Speer; K Harms; H L Halliday; T Curstedt; B Robertson
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.